Our analysis showed that supplementation of ω-3 PUFA was efficacious in patients with NAFLD in decreasing ALT and TC, especially in decreasing TG, and increasing HDL-C. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.